This brand name is authorized in Cyprus, Estonia, Finland, New Zealand, Romania, Singapore
The drug MALTOFER contains one active pharmaceutical ingredient (API):
|
1
Ferric hydroxide polymaltose complex
UNII UM5219H89V - IRON POLYMALTOSE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AB05 | Ferric oxide polymaltose complexes | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AB Iron trivalent, oral preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1150029 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 463430, 507632 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 18759, 18841 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W44026001, W51229001 |
| Country: SG | Health Sciences Authority | Identifier(s): 05699P, 05700P, 14981P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
